BIONET Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 246.3 million compared to TWD 226.79 million a year ago. Net income was TWD 15.78 million compared to TWD 5.38 million a year ago. Basic earnings per share from continuing operations was TWD 0.34 compared to TWD 0.11 a year ago. Diluted earnings per share from continuing operations was TWD 0.34 compared to TWD 0.11 a year ago.
For the nine months, sales was TWD 718.32 million compared to TWD 702.27 million a year ago. Net income was TWD 27.51 million compared to TWD 29.03 million a year ago. Basic earnings per share from continuing operations was TWD 0.58 compared to TWD 0.61 a year ago. Diluted earnings per share from continuing operations was TWD 0.58 compared to TWD 0.61 a year ago.